Drug
Arct 165
Arct 165: highest development phase Phase 1/2, developed by Arcturus Therapeutics. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1/2
- Developer
- Arcturus Therapeutics
Trials
| Drug | Phase | Indication |
|---|---|---|
| ARCT-165 NCT05037097 | Phase 1/2 | COVID-19 |
Latest
No recent events.
Follow Arct 165 on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.